breast cancer Archives
Feb. 27, 2020—Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.
Jan. 16, 2020—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
The American College of Medical Genetics and Genomics advises evaluating all breast cancer patients to determine the need for genetic testing
Dec. 13, 2019—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
Nov. 20, 2019—A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer
Oct. 24, 2019—David Page, MD, former professor of Pathology and Preventive Medicine at Vanderbilt University School of Medicine, whose work revolutionized the assessment of breast cancer risk, died in Nashville on Thursday, Oct. 17. He was 78.
Oct. 24, 2019—Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.
Oct. 17, 2019—A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.
Oct. 10, 2019—A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.
Sep. 5, 2019— by Tom Wilemon Genetic testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies, according to research published Aug. 29 in JAMA Oncology. In the study, 100 patients were tested regardless of whether they met the current National...